Bolbostemma paniculatum
Contents
Nomenclature
Other Names:
Historical Use of Bolbostemma paniculatum
Bolbostemma paniculatum in Traditional Chinese Medicine
Background
Chinese Name (pinyin): Tubeimu
Chinese Name :
Common Name :Paniculate Bolbostemma
Specific Name : Rhizoma bolbostemmae
Scientific Name:
Collection : The drug is collected in autumn, wash clean, broken off, boiled until no white core observe and dried in the sun.
Description : Irregular masses varying in size, externally reddish brown or dark brown, bumpy. Texture hard, uneasily broken, fracture horny, bright and smooth, odour slight, taste slightly bitter.
Identification :
Processing :
Action : To dissolve lumps, cause subsidence of swelling, and counteract toxicity.
Indication : mastitis, chronic lymphadenitis, tuberculosis of cervical lymph nodes, hypertrophic rhinitis
Precautions :
Dosage : 4.5 to 9 g.
Storage : Preserve in a ventilated and dry place.
Synonymns for Bolbostemma paniculatum
Patent Medicines and Medicines with Multiple Ingredients that include Bolbostemma paniculatum
Pharmaceutical Information
Chemical Constituents
Evidence or the Use of Bolbostemma paniculatum in the Treatment of Epilepesy
Basic Science
Animal Studies
Cohort, Case-Control and Non-Randomized Trials
Randomized Controlled Trials
Meta-Analysis
1st Five Results: pubmed search
Yuanyuan Ou, Sai Qiao, Ting Li, Xinxin Zheng, Xue Zhao, Lejing Qu, Xinfeng Zhao, Yajun Zhang
Affinity Chromatographic Method for Determining Drug-Protein Interaction with Enhanced Speed Than Typical Frontal Analysis.
Langmuir: 2023, 39(29);10259-10269
[PubMed:37454390]
[WorldCat.org]
[DOI]
(I p)
Ziyi Han, Junjie Jin, Xiangfeng Chen, Yanfei He, Hongxiang Sun
Adjuvant activity of tubeimosides by mediating the local immune microenvironment.
Front Immunol: 2023, 14;1108244
[PubMed:36845089]
[WorldCat.org]
[DOI]
(I e)
Xuesong Feng, Guangyuan Ma, Hailong Shi, Yuewen Wang, Xu Chao
Corrigendum: An integrative serum pharmacology-based approach to study the anti-tumor activity of B. Paniculatum aqueous bulb extract on the human hepatocellular carcinoma cell line BEL-7404.
Front Pharmacol: 2022, 13;1054143
[PubMed:36425573]
[WorldCat.org]
[DOI]
(P e)
Yujiao Zhou, Junyu Liu, Jianqiong Zhang, Yi Xu, Wangni Li, Pang Gao, Yanghuan Xing, Lehong Huang, Xuhua Qin, Shenrui Jin
##Title##
Front Pharmacol: 2022, 13;974054
[PubMed:36160391]
[WorldCat.org]
[DOI]
(P e)
Qingfa Tang, Haihong Cao, Ni Tong, Yuanliang Liu, Wanyu Wang, Yuheng Zou, Lanyang Xu, Zhiyun Zeng, Wei Xu, Zhixin Yin, Wenjuan Ma, Qirui Wang
Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.
Phytomedicine: 2022, 99;154016
[PubMed:35278900]
[WorldCat.org]
[DOI]
(I p)
